Tag: Pan-KRAS Inhibitor
Cooley advises Jacobio’s USD2bn licensing deal with AstraZeneca
Cooley has advised Jacobio Pharmaceuticals on a record-breaking USD 2.02 billion global licensing agreement with AstraZeneca
Cooley has advised Jacobio Pharmaceuticals on a record-breaking USD 2.02 billion global licensing agreement with AstraZeneca
Walter Chia, the chief representative officer for Asia-Pacific at INTA, elaborates on factors shaping IP across the region
Follow us on LinkedIn